EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC 4.0

Central-boost Ablative Radiation Therapy for Solid Tumors: Study Protocol of a Single-arm, Phase II Trial (CBART)

Lingong Jiang, Yangsen Cao, Xiaolan Yin, Chunshan Yu, Yusheng Ye, Xiaofei Zhu iD, Huojun Zhang

Technology in Cancer Research & Treatment · 2025

DOI: 10.1177/15330338251350833 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Technology in Cancer Research & Treatment, 2025. Verfasst von Lingong Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Changhai Hospital affiliated to Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Neoplasms, Radiosurgery. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Ministry of Science and Technology of the Peoples’ Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Though stereotactic body radiation therapy (SBRT) has been widely used in advanced tumors, ablative doses may not be appropriate in the case of large tumors or those abutting to the gastrointestinal tracts, resulting in unfavorable outcomes. Therefore, partial irradiation with high doses to tumors have been investigated. In order to achieve a larger high dose area within the tumor center, we developed a novel radiation modality, which was central-boost ablative radiation therapy (CBART). It was delivered by SBRT, with a central ablative dose in the tumor and a relatively low margin dose. And we tried to assess the efficacy of CBART for patients with large tumors or tumors adjacent to the gastrointestinal tracts.

Methods

It is a prospective, single-arm, phase II trial. Eligible patients would receive CBART. Gross tumor volume (GTV) was defined as a radiographically evident gross disease. The margin of GTV was shrinked to form central core GTV (cGTV). The volume of cGTV should be 50% of GTV volume. A 2-5 mm margin expansion on GTV formed planning target volume (PTV). While no margin expansion was performed on cGTV. The prescription dose of tumor margin was 30-45Gy/5f, determined by the tumor location and pathological features. While the prescription dose of cGTV was 120%-150% of that of tumor margin. Ninety percent of PTV and cGTV should be covered by the prescription dose. After CBART, sequential systemic therapy, including chemotherapy, targeted therapy or immunotherapy would be given according to pathological types and tumor stages. The primary outcome is one-year local control rate.

Discussion

An ablative dose to the hypoxic tumor center while a relatively low dose to the tumor margin may improve local control in the case of large tumors or those abutting the gastrointestinal tracts. Further investigations are required to assess the clinical benefits of CBART.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsRadiosurgeryFemaleHumansMaleClinical Trials, Phase II as TopicProspective StudiesRadiotherapy DosageRadiotherapy Planning, Computer-AssistedTreatment OutcomeTumor Burden

Stichwörter der Autor:innen

ablative radiotherapycentral boostlarge tumorstereotactic body radiation therapy

Autor:innen und Institutionen

  • Department of Radiation Oncology, Changhai Hospital affiliated to Naval Medical University, Shanghai, China.
  • Cancer Center, Shanghai 411 Hospital, China RongTong Medical Healthcare Group Co. Ltd./411 Hospital, Shanghai University, Shanghai, China.

ORCID-Profile: Xiaofei Zhu

Förderung

  • the Ministry of Science and Technology of the Peoples’ Republic of China

Zitieren

APA

Jiang, L., Cao, Y., Yin, X., Yu, C., Ye, Y., Zhu, X., & Zhang, H. (2025). Central-boost Ablative Radiation Therapy for Solid Tumors: Study Protocol of a Single-arm, Phase II Trial (CBART). Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338251350833

Vancouver

Jiang L, Cao Y, Yin X, Yu C, Ye Y, Zhu X, et al. Central-boost Ablative Radiation Therapy for Solid Tumors: Study Protocol of a Single-arm, Phase II Trial (CBART). Technology in Cancer Research & Treatment. 2025. doi:10.1177/15330338251350833

BibTeX
@article{Jiang2025,
  author = {Jiang, Lingong and Cao, Yangsen and Yin, Xiaolan and Yu, Chunshan and Ye, Yusheng and Zhu, Xiaofei and Zhang, Huojun},
  title = {Central-boost Ablative Radiation Therapy for Solid Tumors: Study Protocol of a Single-arm, Phase II Trial (CBART)},
  journal = {Technology in Cancer Research & Treatment},
  year = {2025},
  doi = {10.1177/15330338251350833}
}
Kostenlos starten →